NEW YORK (TheStreet) - TheStreet's David Peltier, manager of the Stocks Under $10 portfolio, continues to unearth 2015's top stocks that trade for less than $10. His first pick was Ballantyne Strong (BTN) , and now he's looking at TherapeuticsMD (TXMD) .

Shares of the pharmaceutical company trade at about $4.25. Though the stock is down about 18% this year, Peltier believes it has upside in 2015. 

TherapeuticsMD hasn't been able to keep pace with other biotech stocks this year, as the iShares Nasdaq Biotechnology Index ETF (IBB)  has climbed 35% and SPDR S&P Biotech ETF (XBI) has risen 43.5% in 2014. 

TXMD Chart
TherapeuticsMD TXMD data by YCharts

Peltier, however, said he believes that TherapeuticsMD can climb into the "high single digits" range. The company has a "solid" management team, he said, and has two female hormone replacement therapy treatments in Phase 3 clinical trials. Revenue rose 82% to $4.2 million in its latest quarter.

As an aside, Peltier has also dug up many of 2015's top dividend plays headed into the new year, including such stocks as Lockheed Martin  (LMT) , General Electric  (GE) , Tompkins Financial  (TMP)   and Sonoco Products  (SON) .

-- Written by Bret Kenwell 

Follow @BretKenwell

This article is commentary by an independent contributor. At the time of publication, Kenwell was long GE.

More from Opinion

Recent Warnings From Chipmakers Aren't Just About Weaker Demand

Recent Warnings From Chipmakers Aren't Just About Weaker Demand

Flashback Friday: Nvidia Is the Ultimate Chip and Dip

Flashback Friday: Nvidia Is the Ultimate Chip and Dip

Throwback Thursday: Have No Fear, Cramer's Here to Stave Off the Hungry Bears

Throwback Thursday: Have No Fear, Cramer's Here to Stave Off the Hungry Bears

Cisco Jumps After Beating Estimates: 5 Key Takeaways

Cisco Jumps After Beating Estimates: 5 Key Takeaways

Wednesday Wrap-Up: The Bear Bites Into Apple

Wednesday Wrap-Up: The Bear Bites Into Apple